Canada markets open in 9 hours 8 minutes

Small Pharma Inc. (DMT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.3800-0.0050 (-1.30%)
At close: 3:22PM EDT
Full screen
Previous Close0.3850
Bid0.3650 x N/A
Ask0.3800 x N/A
Day's Range0.3600 - 0.3950
52 Week Range0.3250 - 1.1000
Avg. Volume70,514
Market Cap120.384M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1730
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
  • GlobeNewswire

    Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy

    Small Pharma’s DMT-assisted therapy (SPL026) demonstrated to be well-tolerated and safe in psychedelic naïve volunteers Dataset generated from Phase I enables the selection of the optimal dose of SPL026 to take forward into Phase IIa Small Pharma’s Phase IIa clinical trial to explore the effectiveness of SPL026 in combination with psychotherapy for the treatment of Major Depressive Disorder has been initiated LONDON, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company”

  • Newsfile

    Negev Capital "Doubled Down" on Its Sizable Investment in Small Pharma Inc.

    Toronto, Ontario--(Newsfile Corp. - September 21, 2021) - Negev Capital, a psychedelic medical intervention investment fund, has recently "doubled down" on its sizable investment in Small Pharma Inc (TSXV: DMT), a neuropharmaceutical company specialised in IP-led development of novel treatments for mental health conditions, with a focus on depression.Negev Capital has a broader strategic relationship with Small Pharma, and this latest investment increases the cumulative investment to (USD)$1 mil

  • GlobeNewswire

    Small Pharma Included in AdvisorShares® Newly Launched Psychedelics ETF

    The AdvisorShares® Psychedelics ETF has commenced trading under ticker NYSE: PSILLONDON, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, announces today that AdvisorShares® Investments LLC (“AdvisorShares”), a leading sponsor of actively managed exchange-traded funds (ETFs) has included Small Pharma in the inaugural launch of its AdvisorShares Psychedelics ETF (PSIL). PSIL